Innovation Pharmaceuticals Inc
OTC:IPIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innovation Pharmaceuticals Inc
OTC:IPIX
|
US |
|
A
|
Aurelius Technologies Bhd
KLSE:ATECH
|
MY |
|
Firefly Metals Ltd
ASX:FFM
|
AU |
|
E
|
EA Technique (M) Bhd
KLSE:EATECH
|
MY |
|
B
|
Bannix Acquisition Corp
NASDAQ:BNIX
|
US |
|
Sensera Ltd
ASX:SE1
|
AU |
|
D
|
Daya Intiguna Yasa Tbk PT
IDX:MDIY
|
ID |
|
Link and Motivation Inc
TSE:2170
|
JP |
|
Talon Metals Corp
TSX:TLO
|
VG |
|
Enseval Putera Megatrading Tbk PT
IDX:EPMT
|
ID |
|
I
|
Interlink Telecom PCL
SET:ITEL
|
TH |
|
S
|
Sionna Therapeutics Inc
NASDAQ:SION
|
US |
Bankruptcy Probability
Innovation Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Innovation Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Innovation Pharmaceuticals Inc
OTC:IPIX
|
103.7k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Innovation Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Innovation Pharmaceuticals Inc has total debt of 695k USD. This includes both short-term (238k USD) and long-term (457k USD) debt.
You can find a full breakdown on its Balance Sheet.
